Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccinationEddy Pérez-Then, Akiko Iwasaki, Elena De la Cruz et al.|Nature Medicine|2022Cited by 418
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunityCarolina Lucas, Akiko Iwasaki, Chantal B. F. Vogels et al.|Nature|2021Cited by 260
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2Chantal B. F. Vogels, Nathan D. Grubaugh, Mallery I. Breban et al.|PLoS Biology|2021Cited by 233
Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infectionChrispin Chaguza, Nathan D. Grubaugh, Anne M. Hahn et al.|Cell Reports Medicine|2023Cited by 107